301 related articles for article (PubMed ID: 16076251)
1. Coexpression of formylglycine-generating enzyme is essential for synthesis and secretion of functional arylsulfatase A in a mouse model of metachromatic leukodystrophy.
Takakusaki Y; Hisayasu S; Hirai Y; Shimada T
Hum Gene Ther; 2005 Aug; 16(8):929-36. PubMed ID: 16076251
[TBL] [Abstract][Full Text] [Related]
2. AAV1 mediated co-expression of formylglycine-generating enzyme and arylsulfatase a efficiently corrects sulfatide storage in a mouse model of metachromatic leukodystrophy.
Kurai T; Hisayasu S; Kitagawa R; Migita M; Suzuki H; Hirai Y; Shimada T
Mol Ther; 2007 Jan; 15(1):38-43. PubMed ID: 17164773
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy for metachromatic leukodystrophy.
Ohashi T; Watabe K; Sato Y; Saito I; Barranger JA; Matalon R; Eto Y
Acta Paediatr Jpn; 1996 Apr; 38(2):193-201. PubMed ID: 8677802
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo cell-mediated gene therapy for metachromatic leukodystrophy using neurospheres.
Kawabata K; Migita M; Mochizuki H; Miyake K; Igarashi T; Fukunaga Y; Shimada T
Brain Res; 2006 Jun; 1094(1):13-23. PubMed ID: 16729983
[TBL] [Abstract][Full Text] [Related]
5. Transduced fibroblasts and metachromatic leukodystrophy lymphocytes transfer arylsulfatase A to myelinating glia and deficient cells in vitro.
Sangalli A; Taveggia C; Salviati A; Wrabetz L; Bordignon C; Severini GM
Hum Gene Ther; 1998 Sep; 9(14):2111-9. PubMed ID: 9759937
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of arylsulfatase A gene in fibroblasts from metachromatic leukodystrophy patients does not induce a new phenotype.
Ohashi T; Matalon R; Barranger JA; Eto Y
Gene Ther; 1995 Aug; 2(6):363-8. PubMed ID: 7584110
[TBL] [Abstract][Full Text] [Related]
7. Arylsulfatase A Overexpressing Human iPSC-derived Neural Cells Reduce CNS Sulfatide Storage in a Mouse Model of Metachromatic Leukodystrophy.
Doerr J; Böckenhoff A; Ewald B; Ladewig J; Eckhardt M; Gieselmann V; Matzner U; Brüstle O; Koch P
Mol Ther; 2015 Sep; 23(9):1519-31. PubMed ID: 26061647
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of enzyme replacement therapy in an aggravated mouse model of metachromatic leukodystrophy declines with age.
Matthes F; Stroobants S; Gerlach D; Wohlenberg C; Wessig C; Fogh J; Gieselmann V; Eckhardt M; D'Hooge R; Matzner U
Hum Mol Genet; 2012 Jun; 21(11):2599-609. PubMed ID: 22388935
[TBL] [Abstract][Full Text] [Related]
9. Long-term correction of biochemical and neurological abnormalities in MLD mice model by neonatal systemic injection of an AAV serotype 9 vector.
Miyake N; Miyake K; Asakawa N; Yamamoto M; Shimada T
Gene Ther; 2014 Apr; 21(4):427-33. PubMed ID: 24572788
[TBL] [Abstract][Full Text] [Related]
10. Successful transduction of oligodendrocytes and restoration of arylsulfatase A deficiency in metachromatic leukodystrophy fibroblasts using an adenovirus vector.
Ohashi T; Watabe K; Sato Y; Saito I; Barranger JA; Eto Y
Gene Ther; 1995 Sep; 2(7):443-9. PubMed ID: 7584122
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow stem cell-based gene transfer in a mouse model for metachromatic leukodystrophy: effects on visceral and nervous system disease manifestations.
Matzner U; Hartmann D; Lüllmann-Rauch R; Coenen R; Rothert F; Månsson JE; Fredman P; D'Hooge R; De Deyn PP; Gieselmann V
Gene Ther; 2002 Jan; 9(1):53-63. PubMed ID: 11850723
[TBL] [Abstract][Full Text] [Related]
12. Measurement of recombinant human arylsulfatase A and leukocyte sulfatase activities by analytical isotachophoresis.
Pajarola S; Weißenberg C; Baysal F; Bruchelt G; Krägeloh-Mann I; Böhringer J
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Aug; 1124():109-113. PubMed ID: 31195190
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow stem cell gene therapy of arylsulfatase A-deficient mice, using an arylsulfatase A mutant that is hypersecreted from retrovirally transduced donor-type cells.
Matzner U; Schestag F; Hartmann D; Lüllmann-Rauch R; D'Hooge R; De Deyn PP; Gieselmann V
Hum Gene Ther; 2001 Jun; 12(9):1021-33. PubMed ID: 11399225
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy in metachromatic leukodystrophy.
Sevin C; Cartier-Lacave N; Aubourg P
Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S128-31. PubMed ID: 20040324
[TBL] [Abstract][Full Text] [Related]
15. Developing therapeutic approaches for metachromatic leukodystrophy.
Patil SA; Maegawa GH
Drug Des Devel Ther; 2013; 7():729-45. PubMed ID: 23966770
[TBL] [Abstract][Full Text] [Related]
16. Transduction of fibroblasts and CD34+ progenitors using a selectable retroviral vector containing cDNAs encoding arylsulfatase A and CD24.
Tsutsudaasano A; Migita M; Takahashi K; Shimada T
J Hum Genet; 2000; 45(1):18-23. PubMed ID: 10697958
[TBL] [Abstract][Full Text] [Related]
17. An adult-type metachromatic leukodystrophy caused by substitution of serine for glycine-122 in arylsulfatase A.
Honke K; Kobayashi T; Fujii T; Gasa S; Xu M; Takamaru Y; Kondo R; Tsuji S; Makita A
Hum Genet; 1993 Nov; 92(5):451-6. PubMed ID: 7902317
[TBL] [Abstract][Full Text] [Related]
18. Intracerebroventricular enzyme infusion corrects central nervous system pathology and dysfunction in a mouse model of metachromatic leukodystrophy.
Stroobants S; Gerlach D; Matthes F; Hartmann D; Fogh J; Gieselmann V; D'Hooge R; Matzner U
Hum Mol Genet; 2011 Jul; 20(14):2760-9. PubMed ID: 21515587
[TBL] [Abstract][Full Text] [Related]
19. Retrovirally expressed human arylsulfatase A corrects the metabolic defect of arylsulfatase A-deficient mouse cells.
Matzner U; Habetha M; Gieselmann V
Gene Ther; 2000 May; 7(9):805-12. PubMed ID: 10822308
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy of metachromatic leukodystrophy.
Matzner U; Gieselmann V
Expert Opin Biol Ther; 2005 Jan; 5(1):55-65. PubMed ID: 15709909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
